Telomere-length dependent T-cell clonal expansion: A model linking ageing to COVID-19 T-cell lymphopenia and mortality.
Level 5 - mechanism / opinion, no new human data
Mechanism-based computational modeling study without new clinical or human experimental data.
PubMed 35367774 · doi:10.1016/j.ebiom.2022.103978
What was done
The authors constructed a mathematical model to estimate age-dependent T-cell clonal expansion capacity based on hematopoietic cell telomere length (HCTL). Using this model, they virtually simulated the relationship between age-related loss of T-cell expansion potential and COVID-19 mortality patterns in the general population.
What was found
In the simulation, an individual starting with average HCTL at age 20 maintains maximal T-cell clonal expansion capacity through the fifth decade of life. Clonal expansion capacity then rapidly declines by more than 90% over the next ten years (during the sixth decade), coinciding with the steep increase in age-associated COVID-19 mortality.
Why it matters
The model offers a mechanism-based framework linking age-related telomere attrition to severe COVID-19 T-cell lymphopenia and elevated mortality in older adults.
Limits
This is purely an in silico mathematical simulation with no direct clinical cohort or experimental patient data reported in the abstract. Real-world validation, individual-level immune variations, comorbidities, and pathogen dynamics were not directly measured.
Cited by
- context In COVID-19, immune senescence characterized by short telomeres in T lymphocytes was a lethal factor.